Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 17996 entries
Sorted by: Best Match Show Resources per page
3D SERS substrate based on Au-Ag bi-metal nanoparticles/MoS.

Optics express

Xu J, Li C, Si H, Zhao X, Wang L, Jiang S, Wei D, Yu J, Xiu X, Zhang C.
PMID: 30130861
Opt Express. 2018 Aug 20;26(17):21546-21557. doi: 10.1364/OE.26.021546.

It is very vital to construct the dense hot spots for the strong surface-enhanced Raman scattering (SERS) signals. We take full advantage of the MoS

Cite
Xu J, Li C, Si H, et al. 3D SERS substrate based on Au-Ag bi-metal nanoparticles/MoS. Opt Express. 2018;26(17):21546-21557doi: 10.1364/OE.26.021546.
Xu, J., Li, C., Si, H., Zhao, X., Wang, L., Jiang, S., Wei, D., Yu, J., Xiu, X., & Zhang, C. (2018). 3D SERS substrate based on Au-Ag bi-metal nanoparticles/MoS. Optics express, 26(17), 21546-21557. https://doi.org/10.1364/OE.26.021546
Xu, Jihua, et al. "3D SERS substrate based on Au-Ag bi-metal nanoparticles/MoS." Optics express vol. 26,17 (2018): 21546-21557. doi: https://doi.org/10.1364/OE.26.021546
Xu J, Li C, Si H, Zhao X, Wang L, Jiang S, Wei D, Yu J, Xiu X, Zhang C. 3D SERS substrate based on Au-Ag bi-metal nanoparticles/MoS. Opt Express. 2018 Aug 20;26(17):21546-21557. doi: 10.1364/OE.26.021546. PMID: 30130861.
Copy Download .nbib Format: NLM
Lamotrigine decreases MRP8 and IL-7 in rat models of intractable epilepsy secondary to focal cortical dysplasia.

Experimental and therapeutic medicine

Wei J, Nie Q, Li F.
PMID: 28105099
Exp Ther Med. 2016 Dec;12(6):3694-3698. doi: 10.3892/etm.2016.3806. Epub 2016 Oct 14.

The aim of the present study was to examine the effect of lamotrigine and the expression of myeloid-related protein 8 (MRP8) and interleukin-7 (IL-7) in the treatment of focal cortical dysplasia with secondary intractable epilepsy. In this study, rats...

Cite
Wei J, Nie Q, Li F. Lamotrigine decreases MRP8 and IL-7 in rat models of intractable epilepsy secondary to focal cortical dysplasia. Exp Ther Med. 2016;12(6):3694-3698doi: 10.3892/etm.2016.3806.
Wei, J., Nie, Q., & Li, F. (2016). Lamotrigine decreases MRP8 and IL-7 in rat models of intractable epilepsy secondary to focal cortical dysplasia. Experimental and therapeutic medicine, 12(6), 3694-3698. https://doi.org/10.3892/etm.2016.3806
Wei, Jianping, et al. "Lamotrigine decreases MRP8 and IL-7 in rat models of intractable epilepsy secondary to focal cortical dysplasia." Experimental and therapeutic medicine vol. 12,6 (2016): 3694-3698. doi: https://doi.org/10.3892/etm.2016.3806
Wei J, Nie Q, Li F. Lamotrigine decreases MRP8 and IL-7 in rat models of intractable epilepsy secondary to focal cortical dysplasia. Exp Ther Med. 2016 Dec;12(6):3694-3698. doi: 10.3892/etm.2016.3806. Epub 2016 Oct 14. PMID: 28105099; PMCID: PMC5228364.
Copy Download .nbib Format: NLM
Improving the Halogen-Magnesium Exchange by using New Turbo-Grignard Reagents.

Chemistry (Weinheim an der Bergstrasse, Germany)

Ziegler DS, Wei B, Knochel P.
PMID: 30230067
Chemistry. 2019 Feb 21;25(11):2695-2703. doi: 10.1002/chem.201803904. Epub 2018 Dec 17.

This Minireview describes the scope of the halogen-magnesium exchange. It shows that the use of the turbo-Grignard reagent (iPrMgCl⋅LiCl) greatly enhances the rate of the Br- and I-Mg exchange. Furthermore, this magnesium reagent allows the performance of a fast...

Cite
Ziegler DS, Wei B, Knochel P. Improving the Halogen-Magnesium Exchange by using New Turbo-Grignard Reagents. Chemistry. 2018;25(11):2695-2703doi: 10.1002/chem.201803904.
Ziegler, D. S., Wei, B., & Knochel, P. (2019). Improving the Halogen-Magnesium Exchange by using New Turbo-Grignard Reagents. Chemistry (Weinheim an der Bergstrasse, Germany), 25(11), 2695-2703. https://doi.org/10.1002/chem.201803904
Ziegler, Dorothée S, et al. "Improving the Halogen-Magnesium Exchange by using New Turbo-Grignard Reagents." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,11 (2019): 2695-2703. doi: https://doi.org/10.1002/chem.201803904
Ziegler DS, Wei B, Knochel P. Improving the Halogen-Magnesium Exchange by using New Turbo-Grignard Reagents. Chemistry. 2019 Feb 21;25(11):2695-2703. doi: 10.1002/chem.201803904. Epub 2018 Dec 17. PMID: 30230067.
Copy Download .nbib Format: NLM
Multichannel wide-field microscopic FRET imaging based on simultaneous spectral unmixing of excitation and emission spectra.

Journal of microscopy

Du M, Mai Z, Yang F, Lin F, Wei L, Chen T.
PMID: 28758212
J Microsc. 2018 Jan;269(1):66-77. doi: 10.1111/jmi.12609. Epub 2017 Jul 31.

Simultaneous spectral unmixing of excitation and emission spectra (ExEm unmixing) has inherent ability resolving spectral crosstalks, two key issues of quantitative fluorescence resonance energy transfer (FRET) measurement, of both the excitation and emission spectra between donor and acceptor without...

Cite
Du M, Mai Z, Yang F, et al. Multichannel wide-field microscopic FRET imaging based on simultaneous spectral unmixing of excitation and emission spectra. J Microsc. 2017;269(1):66-77doi: 10.1111/jmi.12609.
Du, M., Mai, Z., Yang, F., Lin, F., Wei, L., & Chen, T. (2018). Multichannel wide-field microscopic FRET imaging based on simultaneous spectral unmixing of excitation and emission spectra. Journal of microscopy, 269(1), 66-77. https://doi.org/10.1111/jmi.12609
Du, M, et al. "Multichannel wide-field microscopic FRET imaging based on simultaneous spectral unmixing of excitation and emission spectra." Journal of microscopy vol. 269,1 (2018): 66-77. doi: https://doi.org/10.1111/jmi.12609
Du M, Mai Z, Yang F, Lin F, Wei L, Chen T. Multichannel wide-field microscopic FRET imaging based on simultaneous spectral unmixing of excitation and emission spectra. J Microsc. 2018 Jan;269(1):66-77. doi: 10.1111/jmi.12609. Epub 2017 Jul 31. PMID: 28758212.
Copy Download .nbib Format: NLM
Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy.

Lung Cancer (Auckland, N.Z.)

Yu B, Lu Y, Gao F, Jing P, Wei H, Zhang P, Liu G, Ru N, Cui G, Xu X, Sun C, Guan C, Che Y, Wu Y, Ma Z, Fu Q, Liu J, Wang HY.
PMID: 28210146
Lung Cancer (Auckl). 2015 Jan 07;6:1-11. doi: 10.2147/LCTT.S70679. eCollection 2015.

AIM: The objective of the study reported here was to evaluate the therapeutic effects of hapten-enhanced chemoimmunotherapy in the treatment of advanced lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy (UMIPIC) and to analyze the effect of this immune...

Cite
Yu B, Lu Y, Gao F, et al. Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy. Lung Cancer (Auckl). 2015;6:1-11doi: 10.2147/LCTT.S70679.
Yu, B., Lu, Y., Gao, F., Jing, P., Wei, H., Zhang, P., Liu, G., Ru, N., Cui, G., Xu, X., Sun, C., Guan, C., Che, Y., Wu, Y., Ma, Z., Fu, Q., Liu, J., & Wang, H. Y. (2015). Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy. Lung Cancer (Auckland, N.Z.), 61-11. https://doi.org/10.2147/LCTT.S70679
Yu, Baofa, et al. "Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy." Lung Cancer (Auckland, N.Z.) vol. 6 (2015): 1-11. doi: https://doi.org/10.2147/LCTT.S70679
Yu B, Lu Y, Gao F, Jing P, Wei H, Zhang P, Liu G, Ru N, Cui G, Xu X, Sun C, Guan C, Che Y, Wu Y, Ma Z, Fu Q, Liu J, Wang HY. Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy. Lung Cancer (Auckl). 2015 Jan 07;6:1-11. doi: 10.2147/LCTT.S70679. eCollection 2015. PMID: 28210146; PMCID: PMC5217516.
Copy Download .nbib Format: NLM
CeO₂ Nanorods Embedded in Ni(OH)₂ Matrix for the Non-Enzymatic Detection of Glucose.

Nanomaterials (Basel, Switzerland)

Li Y, Guan P, Yu F, Li W, Xie X.
PMID: 28758973
Nanomaterials (Basel). 2017 Jul 31;7(8). doi: 10.3390/nano7080205.

The electrode based on cerium oxide (CeO₂) nanorods embedded in nickel hydroxide (Ni(OH)₂) matrix were prepared and used for detecting glucose non-enzymatically. The materials were characterized by X-ray diffraction, transmission electron microscopy (TEM), and so on. The results indicate...

Cite
Li Y, Guan P, Yu F, et al. CeO₂ Nanorods Embedded in Ni(OH)₂ Matrix for the Non-Enzymatic Detection of Glucose. Nanomaterials (Basel). 2017;7(8)doi: 10.3390/nano7080205.
Li, Y., Guan, P., Yu, F., Li, W., & Xie, X. (2017). CeO₂ Nanorods Embedded in Ni(OH)₂ Matrix for the Non-Enzymatic Detection of Glucose. Nanomaterials (Basel, Switzerland), 7(8), . https://doi.org/10.3390/nano7080205
Li, Yongjian, et al. "CeO₂ Nanorods Embedded in Ni(OH)₂ Matrix for the Non-Enzymatic Detection of Glucose." Nanomaterials (Basel, Switzerland) vol. 7,8 (2017). doi: https://doi.org/10.3390/nano7080205
Li Y, Guan P, Yu F, Li W, Xie X. CeO₂ Nanorods Embedded in Ni(OH)₂ Matrix for the Non-Enzymatic Detection of Glucose. Nanomaterials (Basel). 2017 Jul 31;7(8). doi: 10.3390/nano7080205. PMID: 28758973; PMCID: PMC5575687.
Copy Download .nbib Format: NLM
MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.

Oncotarget

Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang J, He S, Hu W, Liu X.
PMID: 29296182
Oncotarget. 2017 Nov 18;8(64):107500-107512. doi: 10.18632/oncotarget.22494. eCollection 2017 Dec 08.

Gemcitabine-based chemotherapy is the most common treatment option for pancreatic ductal adenocarcinoma (PDAC). However, it offers little therapeutic value in many cases due to the rapid development of chemoresistance. MicroRNAs (miRNAs) have been found to play pivotal roles in...

Cite
Xiong J, Wang D, Wei A, et al. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Oncotarget. 2017;8(64):107500-107512doi: 10.18632/oncotarget.22494.
Xiong, J., Wang, D., Wei, A., Ke, N., Wang, Y., Tang, J., He, S., Hu, W., & Liu, X. (2017). MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Oncotarget, 8(64), 107500-107512. https://doi.org/10.18632/oncotarget.22494
Xiong, Junjie, et al. "MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy." Oncotarget vol. 8,64 (2017): 107500-107512. doi: https://doi.org/10.18632/oncotarget.22494
Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang J, He S, Hu W, Liu X. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Oncotarget. 2017 Nov 18;8(64):107500-107512. doi: 10.18632/oncotarget.22494. eCollection 2017 Dec 08. PMID: 29296182; PMCID: PMC5746084.
Copy Download .nbib Format: NLM
Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta?.

Protein & cell

Wei F, Sun X, Gao Y, Dou H, Liu Y, Su L, Luo H, Zhu C, Zhang Q, Tong P, Ren W, Xun Z, Guo R, Guan Y, Li S, Qi Y, Qin J, Chen F, Zheng S.
PMID: 32808158
Protein Cell. 2021 Jun;12(6):502-510. doi: 10.1007/s13238-020-00774-y.

No abstract available.

Cite
Wei F, Sun X, Gao Y, et al. Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta?. Protein Cell. 2021;12(6):502-510doi: 10.1007/s13238-020-00774-y.
Wei, F., Sun, X., Gao, Y., Dou, H., Liu, Y., Su, L., Luo, H., Zhu, C., Zhang, Q., Tong, P., Ren, W., Xun, Z., Guo, R., Guan, Y., Li, S., Qi, Y., Qin, J., Chen, F., & Zheng, S. (2021). Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta?. Protein & cell, 12(6), 502-510. https://doi.org/10.1007/s13238-020-00774-y
Wei, Fangqiao, et al. "Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta?." Protein & cell vol. 12,6 (2021): 502-510. doi: https://doi.org/10.1007/s13238-020-00774-y
Wei F, Sun X, Gao Y, Dou H, Liu Y, Su L, Luo H, Zhu C, Zhang Q, Tong P, Ren W, Xun Z, Guo R, Guan Y, Li S, Qi Y, Qin J, Chen F, Zheng S. Is oral microbiome of children able to maintain resistance and functional stability in response to short-term interference of ingesta?. Protein Cell. 2021 Jun;12(6):502-510. doi: 10.1007/s13238-020-00774-y. PMID: 32808158; PMCID: PMC8160059.
Copy Download .nbib Format: NLM
Influence of Different Aging Environments on Rheological Behavior and Structural Properties of Rubber Asphalt.

Materials (Basel, Switzerland)

Zhang Y, Wei H, Dai Y.
PMID: 32751532
Materials (Basel). 2020 Jul 30;13(15). doi: 10.3390/ma13153376.

Research on asphalt aging properties mainly focuses on temperature and ultraviolet (UV) radiation, while water, acid and salt media in natural environment are often ignored. According to the aging simulation of self-made UV environment chamber, the influence of the...

Cite
Zhang Y, Wei H, Dai Y. Influence of Different Aging Environments on Rheological Behavior and Structural Properties of Rubber Asphalt. Materials (Basel). 2020;13(15)doi: 10.3390/ma13153376.
Zhang, Y., Wei, H., & Dai, Y. (2020). Influence of Different Aging Environments on Rheological Behavior and Structural Properties of Rubber Asphalt. Materials (Basel, Switzerland), 13(15), . https://doi.org/10.3390/ma13153376
Zhang, Yuhao, et al. "Influence of Different Aging Environments on Rheological Behavior and Structural Properties of Rubber Asphalt." Materials (Basel, Switzerland) vol. 13,15 (2020). doi: https://doi.org/10.3390/ma13153376
Zhang Y, Wei H, Dai Y. Influence of Different Aging Environments on Rheological Behavior and Structural Properties of Rubber Asphalt. Materials (Basel). 2020 Jul 30;13(15). doi: 10.3390/ma13153376. PMID: 32751532; PMCID: PMC7435487.
Copy Download .nbib Format: NLM
Achieving Efficient CO.

ACS applied materials & interfaces

Li T, Wei H, Liu T, Zheng G, Liu S, Luo JL.
PMID: 31149792
ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22346-22351. doi: 10.1021/acsami.9b04580. Epub 2019 Jun 12.

Tunable In(OH)

Cite
Li T, Wei H, Liu T, et al. Achieving Efficient CO. ACS Appl Mater Interfaces. 2019;11(25):22346-22351doi: 10.1021/acsami.9b04580.
Li, T., Wei, H., Liu, T., Zheng, G., Liu, S., & Luo, J. L. (2019). Achieving Efficient CO. ACS applied materials & interfaces, 11(25), 22346-22351. https://doi.org/10.1021/acsami.9b04580
Li, Tengfei, et al. "Achieving Efficient CO." ACS applied materials & interfaces vol. 11,25 (2019): 22346-22351. doi: https://doi.org/10.1021/acsami.9b04580
Li T, Wei H, Liu T, Zheng G, Liu S, Luo JL. Achieving Efficient CO. ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22346-22351. doi: 10.1021/acsami.9b04580. Epub 2019 Jun 12. PMID: 31149792.
Copy Download .nbib Format: NLM
Calcineurin-Modulated Antimicrobial Peptide Expression Is Required for the Development of .

Frontiers in physiology

Wei J, Li L, Yao S, Yang S, Zhou S, Liu X, Du M, An S.
PMID: 31681018
Front Physiol. 2019 Oct 17;10:1312. doi: 10.3389/fphys.2019.01312. eCollection 2019.

No abstract available.

Cite
Wei J, Li L, Yao S, et al. Calcineurin-Modulated Antimicrobial Peptide Expression Is Required for the Development of . Front Physiol. 2019;10:1312doi: 10.3389/fphys.2019.01312.
Wei, J., Li, L., Yao, S., Yang, S., Zhou, S., Liu, X., Du, M., & An, S. (2019). Calcineurin-Modulated Antimicrobial Peptide Expression Is Required for the Development of . Frontiers in physiology, 101312. https://doi.org/10.3389/fphys.2019.01312
Wei, Jizhen, et al. "Calcineurin-Modulated Antimicrobial Peptide Expression Is Required for the Development of ." Frontiers in physiology vol. 10 (2019): 1312. doi: https://doi.org/10.3389/fphys.2019.01312
Wei J, Li L, Yao S, Yang S, Zhou S, Liu X, Du M, An S. Calcineurin-Modulated Antimicrobial Peptide Expression Is Required for the Development of . Front Physiol. 2019 Oct 17;10:1312. doi: 10.3389/fphys.2019.01312. eCollection 2019. PMID: 31681018; PMCID: PMC6812685.
Copy Download .nbib Format: NLM
Isobologram Analysis: A Comprehensive Review of Methodology and Current Research.

Frontiers in pharmacology

Huang RY, Pei L, Liu Q, Chen S, Dou H, Shu G, Yuan ZX, Lin J, Peng G, Zhang W, Fu H.
PMID: 31736746
Front Pharmacol. 2019 Oct 29;10:1222. doi: 10.3389/fphar.2019.01222. eCollection 2019.

Drug combination is a common method for clinical disease treatment. Whether the combination of drugs is reasonable often affects the result of the disease treatment. Many methods have been used to evaluate interaction between drugs to date. Isobologram analysis...

Cite
Huang RY, Pei L, Liu Q, et al. Isobologram Analysis: A Comprehensive Review of Methodology and Current Research. Front Pharmacol. 2019;10:1222doi: 10.3389/fphar.2019.01222.
Huang, R. Y., Pei, L., Liu, Q., Chen, S., Dou, H., Shu, G., Yuan, Z. X., Lin, J., Peng, G., Zhang, W., & Fu, H. (2019). Isobologram Analysis: A Comprehensive Review of Methodology and Current Research. Frontiers in pharmacology, 101222. https://doi.org/10.3389/fphar.2019.01222
Huang, Ruo-Yue, et al. "Isobologram Analysis: A Comprehensive Review of Methodology and Current Research." Frontiers in pharmacology vol. 10 (2019): 1222. doi: https://doi.org/10.3389/fphar.2019.01222
Huang RY, Pei L, Liu Q, Chen S, Dou H, Shu G, Yuan ZX, Lin J, Peng G, Zhang W, Fu H. Isobologram Analysis: A Comprehensive Review of Methodology and Current Research. Front Pharmacol. 2019 Oct 29;10:1222. doi: 10.3389/fphar.2019.01222. eCollection 2019. PMID: 31736746; PMCID: PMC6830115.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 17996 entries